2018

• Academic lecture
  Waage, Anders; Hjertner, Øyvind. (2018) Multiple myeloma and associated malignancies, a study on Norwegian registry data. NMSG NMSG-møte september , Helsinki 2018-09-06 - 2018-09-07

2010

• Academic lecture
  Bjelland, Thor Wilhelm; Hjertner, Øyvind; Klepstad, Pål; Kaisen, Kjell; Dale, Ola; Haugen, Bjørn Olav. (2010) Antiplatelet effect of clopidogrel is reduced in patients treated with therapeutic hypothermia after cardiac arrest. Midt-Norsk Kardiologisk Forum 2010-11-18 - 2010-11-19
• Academic lecture
  Bjelland, Thor Wilhelm; Hjertner, Øyvind; Klepstad, Pål; Kaisen, Kjell; Dale, Ola; Haugen, Bjørn Olav. (2010) Antiplatelet effect of clopidogrel is reduced in patients treated with therapeutic hypothermia after cardiac arrest. Frampeik 2010 2010-10-22 - 2010-10-24

2009

• Academic lecture
  Hjertner, ¯yvind. (2009) Bensykdom ved myelomatose. Nordisk Myelomatose Studiegruppe Årsmøte i Nordisk Myelomatose Studiegruppe , København 2009-11-12 - 2009-11-13
• Academic lecture
  Mellqvist, Ulf-Henrik; Westin, Jan; Gimsing, Peter; Hjertner, Øyvind; Lenhoff, Stig; Laane, Edward. (2009) Improved Response Rate with Bortezomib Consolidation After High Dose Melphalan: First Results of a Nordic Myeloma Study Group Randomized Phase III Trial. American Society of Hematology American Society of Hematology , New Orleans 2009-12-05 - 2009-12-08
• Academic lecture
  Hjertner, ¯yvind. (2009) Anbefalinger om behandling av myelomatose. Legeforeningen Årsmøte i Norsk Selskap for hematologi , Lillehammer 2009-03-11 - 2009-03-13

2007

• Academic lecture
  Standal, Therese; Abildgaard, Niels; Fagerli, Unn-Merete; Hjertner, ¯yvind; Størdal, Berit Fladvad; Børset, Magne. (2007) Beinsykdommen ved myelomatose. Er HGF skurken?. Rikshospitalet og St. Olavs Hospital Norsk Beinsymposium: Osteoporose og beinforskning i Norge , Oslo 2007-11-29 - 2007-11-29
• Academic lecture
  Standal, Therese; Abildgaard, Niels; Fagerli, Unn-Merete; Størdal, Berit Fladvad; Hjertner, ¯yvind; Børset, Magne. (2007) HGF:perpetrator of myeloma bone disease?. NTNU Polsk-norsk uke 2007-10-17 - 2007-10-17

2003

• Poster
  Standal, Therese; Hjorth-Hansen, Henrik; Dahl, Ivar M.; Brenne, Anne Tove; Waage, Anders; Børset, Magne. (2003) Elevated plasma OPN in multiple myeloma patients. Multiple Myeloma 9th International Workshop , Salamanca, Spania 2003-05-27 -

2002

• Academic lecture
  Standal, Therese; Seidel, Carina; Hjertner, ¯yvind; Plesner, Torben; Waage, Anders; Børset, Magne. (2002) Osteoprotegerin is bound, internalized and degraded by multiple myeloma cells. 18th UICC International Cancer Congress , Oslo, Norway 2002-07-05 -
• Academic lecture
  Rø, Torstein Baade; Brenne, Anne Tove; Hjertner, ¯yvind; Hjorth-Hansen, Henrik; Sundan, Anders; Waage, Anders. (2002) Bone morphogenetic protein-5, -6 and -7 inhibit proliferation and induce apoptosis in four human myeloma cell lines. 18th UICC International Cancer Congress , Oslo, Norway 2002-07-05 -
• Academic lecture
  Rø, Torstein Baade; Holt, Randi Utne; Brenne, Anne Tove; Waage, Anders; Hjorth-Hansen, Henrik; Hjertner, ¯yvind. (2002) Bone Morphogenetic Protein (BMP) Family Members BMP-5, BMP-6 and BMP-7 Inhibit Proliferation and Induce Apoptosis in Human Myeloma cells. American Society of Hematology Forty-fourth annual meeting , Philadelphia, Pennsylvania 2002-12-10 -
• Academic lecture
  Standahl, Therese; Seidel, Carina; Hjertner, ¯yvind; Plesner, Torben; Sanderson, Ralph D.; Waage, Anders. (2002) Osteoprotegerin (OPG) blir bundet, internalisert og degradert av myelomceller. Vintermøte i Norsk selskap for hematologi , Lillehammer 2002-03-22 -
• Poster
  Standal, Therese; Waage, Anders; Seidel, Carina; Hjertner, ¯yvind; Plesner, Torben; Sanderson, Ralph D.. (2002) Increased clearance of osteoprotegerin (OPG) in multiple myeloma: OPG is internalized and degraded by myeloma cells. Nordisk forening for hematologis vårmøte , Linkøping, Sverige 2002-06-01 -

2001

• Poster
  Seidel, Carina; Hjertner, ¯yvind; Hjorth-Hansen, Henrik; Waage, Anders; Sundan, Anders; Børset, Magne. (2001) OPG levels are reduced in patients with myeloma and correlate with skeletal involvement. Mayo Clinic: The Judith & George Goldman Symposium on Innovative Research in Myeloma , The Ritz Carlton, Amelia Island, Florida, USA 2001-01-21 -
• Poster
  Børset, Magne; Standahl, Therese; Hjertner, ¯yvind; Seidel, Carina; Hjorth-Hansen, Henrik; Waage, Anders. (2001) Binding, Internalization and Degradation of Osteoprotegerin in Human Myeloma Cells. American Society of Hematology 43rd Annual Meeting and Exposition , Orlando, Florida, USA 2001-12-11 -

2000

• Poster
  Seidel, C; Børset, M; Hjertner, ¯yvind; Cao, D; Abildgaard, N; Hjort Hansen, H. (2000) Høye nivåer av løselig syndecan-1 og hepatocyttvekstfaktor (HGF) i beinmark fra myelompasienter: syndecan-1 modulerer biologisk aktivitet av HGF. Nordisk vårmøte i hematologi , København, 11.12. mai
• Popular scientific lecture
  Hjertner, ¯yvind; Hjorth-Hansen, Henrik; Børset, Magne; Seidel, Carina; Waage, Anders; Sundan, Anders. (2000) Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells. American Society of Hematology, Forty-second annual meeting , San Francisco, CA, December 1-5, 2000
• Poster
  Hjertner, ¯yvind; Hjorth-Hansen, Henrik; Børset, Magne; Seidel, Carina; Waage, Anders; Sundan, Anders. (2000) Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells. American Society of Hematology, Forty-sescond annual Meeting , San Francisco, USA, December 1-5, 2000

1999

• Popular scientific lecture
  Hjertner, ¯yvind; Hjorth-Hansen, Henrik; Woodliff, J.; Waage, Anders; Børset, Magne. (1999) Expression of urokinase plasminogen activator (uPA) and the uPA receptor (uPAR) in myeloma cells. American Society of Hematology, 41st Annual Meeting, , New Orleans, December 1999
• Popular scientific lecture
  Hjorth-Hansen, Henrik; Hjertner, ¯yvind; Seidel, Carina; Børset, Magne; Waage, Anders; Sundan, Anders. (1999) Bone morphogenetic protein (BMP)-4 induces apoptosis and inhibits proliferation in myeloma cells by inhibition of the interleukin (IL)-6 signalling pathway. American Society of Hematology 41st Annual Meeting , New Orleans, December 1999
• Popular scientific lecture
  Hjertner, ¯yvind. (1999) Expression of urokinase plasminogen activator (uPA) and the uPA receptor (uPAR) in myeloma cells. The American Society of Hematology 41st Annual Meeting , New Orleans, December 4-7, 1999
• Popular scientific lecture
  Hjorth-Hansen, Henrik; Hjertner, ¯yvind; Børset, Magne; Sundan, Anders; Waage, Anders. (1999) Hepatocyte growth factor (HGF) induces interleukin (IL)-6 production in murine osteoblasts, bone marrow stroma and whole organ cultures of calvariae. American Society of Hematology 41st Annual Meeting , New Orleans, December 1999
• Popular scientific lecture
  Sundan, Anders; Hjertner, ¯yvind; Torgersen, M. Lyngaas; Seidel, Carina; Hjorth-Hansen, Henrik; Waage, Anders. (1999) HGF induces IL-11 secretion from osteoblasts : a possible role for HGFin myeloma-associated bone disease. VII International Multiple Myeloma Workshop , Stockholm, Sweden, September 1-5, 1999

1998

• Poster
  Hjertner, ¯yvind; Torgersen, Maria; Hansen, Henrik Hjort; Børset, Magne; Waage, Anders; Sundan, Anders. (1998) A Role for Hepatocyte Growth factor in Myeloma Cell Proliferation and Bone Disease: Induction of IL-6 and IL-11 from Osteoblatsts. The American society for bone and mineral research and the inte rnational bone and mineral society , San Francisco California
• Poster
  Hjertner, ¯yvind; Torgersen, Maria; Moen, Siv; Børset, Magne; Hjort-Hansen, Henrik; Waage, Anders. (1998) The Expression of hepatocyte growth factor (HGF) and FAS ligands (FAS L) in myeloma cell lines. Biokjemisk kontaktmøte , Lillehammer Hotell, Lillehammer